2018 Sample

2017
Sample Report

Global Cytomegalovirus
Infection Treatment
Market: Market Estimation,
Dynamics, Regional Share,
Trends, Competitor Analysis The Center
2012-2016 and Forecast For
2017-2023 Intelligence

Precision Business Insights

1 ©2018 Precision Business Insights
Sales@Precisionbusinsessinsights.com

Toll Free (US): +1-866-598-1553

Global Cytomegalovirus Infection Treatment Market: Market
Estimation, Dynamics, Regional Share, Trends, Competitor Analysis
2012-2016 and Forecast 2017-2023
Cytomegalovirus (CMV) infection is the common herpes virus infection having different symptoms
which occurs in all ages of people around the world. Cytomegalovirus (CMV) infection is a
communicable and easily prone through the body fluids like urine, saliva, blood, breast milk and
semen. The infection may spread fast from urine or saliva from people who are infected with CMV
having virus in their bodily fluids. The disease can transmit from pregnant to baby during delivery.
Organ transplant and Blood transfusion are the other way for the transmission of the disease.

Cytomegalovirus infection treatment market is mainly propelling by the rise in the prevalence of CMV
infections, growing awareness about herpes disease, pipeline drugs which are promising by key
market players for the treatment of CMV infection. Moreover, rise in the support of government, and
development of healthcare infrastructure are anticipated to fuel the growth of CMV infection treatment
market. However, recent expiries of patented drugs, generic drugs that are available for the treatment
like Ganciclovir & Foscarnet are anticipated to hamper the market growth of cytomegalovirus infection
treatment.

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-cytomegalovirus-infection-
treatment-market/#ulp-4H8Z4LpNMLEuOnnx

The global cytomegalovirus infection market is classified on the basis of drug class, infection,
distribution channel, and geography.

Based on drug class, the global cytomegalovirus infection market is segmented into the following:
 Antiviral drugs
o Foscarnet
o Cytovene
o Vistide
o Others

Based on infection, the global cytomegalovirus infection market is segmented into the following
 Retinitis
 Pneumonia
 Gastroenteritis
 Others (Mouth Ulcers, Pharyngitis, etc.)

Based on distribution channel, the global cytomegalovirus infection market is segmented into the
following:
 Hospital Pharmacies
 Retail Pharmacies
 Others

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-cytomegalovirus-infection-
treatment-market/#ulp-c654SbFYO64MsOhu

2 ©2018 Precision Business Insights

Global cytomegalovirus infection treatment market is anticipated to show effective growth rate in
foresee period. Players in the market are heavily investing in R&D for the development of novel
therapies and drugs to treat cytomegalovirus infection. Moreover, regulatory bodies of the healthcare
sector are having more attention on novel drugs by giving faster approvals and special status for the
drugs. For instance, Merck & Co. Inc., developed Letermovir, antiviral drug for the treatment of CMV
infection. The drug has received fast track status by the U.S. FDA and the orphan drug status by
European Medicines Agency.

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-cytomegalovirus-infection-
treatment-market/#ulp-14mlyhjMGhVjZqa3

On the basis of Geographical regions, CMV infection treatment market is classified as into five key
regions as Europe, Asia- Pacific, North America, Middle East & Africa and Latin America. North
America & Europe were anticipated to contribute major share in the cytomegalovirus infection
treatment market due to the high prevalence rate of cytomegalovirus infection. As per Centre for
Disease Control and Prevention (CDC), approximately, 80,000 cases of CMV infections were
diagnosed in U.S. and Europe. Increased prevalence of cytomegalovirus (CMV) infection in the
developing countries and in the areas of lower economic status. Asia-Pacific is anticipated to grow
rapidly owing to the large patient pool, and rise in prevalence of many infectious diseases as well as
rise in the awareness on cytomegalovirus infections.

Some of the players in cytomegalovirus infection market are F. Hoffmann-La Roche AG (Switzerland),
GlaxoSmithKline plc (U.K.), Merck & Co., Inc. (U.S.), AiCuris Anti-infective Cures GmbH (Germany)
Vical, Inc. (U.S.), Chimerix, Inc. (U.S.) and ViroPharma (U.S.), to name a few.

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-cytomegalovirus-infection-
treatment-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm,
which follow a holistic approach to solve needs of the clients. We adopt and implement new
research methodologies to achieve better results. We help our clients by providing actionable
insights and strategies to make better decisions. We provide consulting, syndicated and
customised market research services based on our client needs.

3 ©2018 Precision Business Insights

Mission

Precision Business Insights mission is to provide high-quality market research reports and
generate key insights to our clients. PBI’s approachable strategies are to help clients to make
key decisions for business growth.

Vision

Precision Business Insights vision is to become most valued partner to fortune 500 companies
by providing agile, accurate, and actionable market insights.

Contact Us :

Europe Office: Asia-Pacific Office:

Kemp House, #202, RVS Sree Homes, Opp : Bharat Petroleum

Pump,
152 – 160 City Road,
Khanamet Road, Hitech City, Hyderabad,
London EC1V 2NX
Telangana, India. Pin: 500084
Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

4 ©2018 Precision Business Insights